Literature DB >> 2542628

Absence of mouse mammary tumor virus proviral amplification in chemically induced lymphomas of RF/J mice.

R Kraft1, S T Ishizaka, S A Okenquist, G Childs, F Lilly, J Lenz.   

Abstract

RF/J mice are susceptible to the induction of thymic lymphomas by the carcinogens 3-methylcholanthrene and N-methyl-N-nitrosourea. Given the association of mouse mammary tumor virus (MMTV) with certain thymomas, we examined genomic DNA from chemically induced lymphomas of RF/J mice for new MMTV proviruses. Of 13 tissue culture lines derived from 3-methylcholanthrene-induced tumors, 5 had acquired new proviruses. MMTV amplification coincided with the appearance of viral mRNAs and proteins. However, no primary tumors or animal-passaged tumors contained new proviruses. These observations indicate that MMTV does not have a role in the tumor induction process, although it may become activated and amplified in tissue culture lines derived from tumors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2542628      PMCID: PMC250883     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

Review 1.  Mutational activation of oncogenes in animal model systems of carcinogenesis.

Authors:  I Guerrero; A Pellicer
Journal:  Mutat Res       Date:  1987-05       Impact factor: 2.433

2.  Molecular cloning and characterization of mouse mammary tumor proviruses from a T-cell lymphoma.

Authors:  J P Dudley; A Arfsten; C L Hsu; C Kozak; R Risser
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

3.  Comparison of endogenous murine leukemia virus proviral organization and RNA expression in 3-methylcholanthrene-induced and spontaneous thymic lymphomas in RF and AKR mice.

Authors:  J Chinsky; M M Goodenow; M Jackson; F Lilly; L Leinwand; G Childs
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

4.  Rearrangements in the long terminal repeat of extra mouse mammary tumor proviruses in T-cell leukemias of mouse strain GR result in a novel enhancer-like structure.

Authors:  R Michalides; E Wagenaar; P Weijers
Journal:  Mol Cell Biol       Date:  1985-04       Impact factor: 4.272

5.  Exogenous mouse mammary tumor virus proviral DNA isolated from a kidney adenocarcinoma cell line contains alterations in the U3 region of the long terminal repeat.

Authors:  R J Wellinger; M Garcia; A Vessaz; H Diggelmann
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

6.  Expression of differentiation and murine leukemia virus antigens on cells of primary tumors and cell lines derived from chemically induced lymphomas of RF/J mice.

Authors:  M M Goodenow; F Lilly
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

7.  Comparison of chemically induced and spontaneous murine thymic lymphomas in RF and AKR mice: differential expression of c-myc and c-myb.

Authors:  J Chinsky; F Lilly; G Childs
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

8.  Absence of trisomy 15 in chemically induced murine T-cell lymphomas.

Authors:  M Goodenow; K Kessler; L Leinwand; F Lilly
Journal:  Cancer Genet Cytogenet       Date:  1986-01-15

9.  A new site of integration for mouse mammary tumor virus proviral DNA common to BALB/cf(C3H) mammary and kidney adenocarcinomas.

Authors:  M Garcia; R Wellinger; A Vessaz; H Diggelmann
Journal:  EMBO J       Date:  1986-01       Impact factor: 11.598

10.  Friend virus-specific cytotoxic T lymphocytes recognize both gag and env gene-encoded specificities.

Authors:  C A Holt; K Osorio; F Lilly
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307

View more
  2 in total

1.  Altered mouse mammary tumor virus transcript synthesis in T-cell lymphoma cells.

Authors:  J Racevskis
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

2.  Mouse mammary tumor virus with rearranged long terminal repeats causes murine lymphomas.

Authors:  S Yanagawa; K Kakimi; H Tanaka; A Murakami; Y Nakagawa; Y Kubo; Y Yamada; H Hiai; K Kuribayashi; T Masuda
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.